Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.

Slides:



Advertisements
Similar presentations
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Advertisements

Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
Epidemiology of Childhood Cancer: Incidence, Survival and Mortality Pediatric Resident Education Series.
Basics of Pediatric Oncology Margret E. Merino, MD Pediatric Hematology/Oncology WRAMC.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
How do cancer rates in your area compare to those in other areas?
Disparities in Cancer September 22, Introduction Despite notable advances in cancer prevention, screening, and treatment, a disproportionate number.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Centers for Disease Control and Prevention CDC Half-Year of Diagnosis** Number of Cases **Adjusted for reporting delay AIDS Cases in Racial/Ethnic Minorities*
Health Consultation: Evaluation of Cancer Incidence in Census Tracts of Attleboro and Norton, Massachusetts: Suzanne K. Condon Associate Commissioner.
Assessing Minority Participation in Clinical Trials: Setting Attainable Goals The Minority and Women Clinical Trials Recruitment Program Department of.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
National Program of Cancer Registries
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
Alaska Native Tumor Registry Alaska Native Epidemiology Center 40-Year Trends in Cancer Incidence among Alaska Native People
 Subhendu De, Wonsuk Yoo Institute of Public and Preventative Health (IPPH), Georgia Regents University On Summer Public Health Scholars Program (SPHSP)
1 PHSKC 4/01 Epidemiology of HIV/AIDS Seattle-King County, WA HIV/AIDS Epidemiology Program Public Health - Seattle & King Co. (206) On the web.
Healthy People 2010 Focus Area 4
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Electronic Dissemination of Hematologic Cancer Survivorship Materials with Application to the Adolescent and Young Adult (AYA) Community OHSU Cancer.
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Healthy People 2010 Focus Area 3: Cancer Progress Review August 17, 2006.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
Healthy People 2010 Focus Area 5: Diabetes Progress Review October 20, 2006.
Cancer in Ontario: Overview A Statistical Report.
Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.
INDICATORS OF HEALTH STATUS Burden of disease Disability Adjusted Life Year (DALY) Health status Morbidity Life expectancy Prevalence Mortality Incidence.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Cancer Incidence and Mortality among Adolescence and Young Adults Age in Florida Youjie Huang, MD, DrPH Tara Hylton, MPH Florida Department of Health,
What does the data tell us? Colorectal CANCER IN NEVADA
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Cancer Statistics 2016 A Presentation from the American Cancer Society
Jun Li, MD MPH Epidemic Intelligence Service Officer
Cancer Statistics 2016 A Presentation from the American Cancer Society
Cervical Cancer in California
2 Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
In Focus 6 Spotlight on Specific Cancers TANYA
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
Sexually Transmitted Disease (STD) Surveillance Report, 2016
It is estimated that about 1
It is estimated that almost 1
Bronx Community Health Dashboard: Other Cancers Last Updated: 01/09/2018 See last slide for more information about this project.
Bronx Community Health Dashboard: Prostate Cancer Last Updated: 1/19/2018 See last slide for more information about this project.
Ovarian Cancer Facts and Figures
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Estimated current cancer incidence
Estimated current cancer mortality
AIDS Trends   For all slides in this series, the following notes apply:
The upper curve represents estimated AIDS incidence (number of new cases); the lower one represents the estimated number of deaths of adults and adolescents.
It is estimated that more than 1
7 Cancer prevalence Ontario Cancer Statistics 2018 Chapter 7: Cancer prevalence.
Citation: Cancer Care Ontario
Siwei Zhang Rongshou Zheng
Cervical Cancer Surveillance, Screening, and Treatment
Trends in survival from metastatic lung cancer in California,
NAACCR/IACR Annual Conference, June 2019
Colorectal cancer survival disparities in California
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Presentation transcript:

Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group

Members Ann Geiger, NCI, Chair Archie Bleyer, Oregon Health and Science University, Co- Chair Ronald Barr, McMaster University Lynne Harlan, NCI Theresa Keegan, Cancer Prevention Institute of California Denis Lewis, NCI Brad Pollock, University of Texas Health Science Center at San Antonio Lynn Ries, NCI (sends her regrets) Deborah Vollmer Dahlke, Texas A&M University Health Science Center

Outline General Introduction & Breast: Ann Melanoma & colorectal: Theresa Leukemia & sarcoma: Denise Beyond SEER: Deborah Additional Observations & Summary: Archie Questions for Discussion: Last Slide

Methods AYA = 15 to 39 years old, inclusive 2000 to 2010 and subintervals SEER 18 (28% of US Population) – Limited publication of population-based, non-site specific cancer epidemiology focused on AYA

Not Done Prevalence Stage at diagnosis for children, AYA, and older adults with the same cancers Only risk factor information is age, sex, and race/ethnicity Interpretation

Caution Incidence and mortality rates per 100,000 – horizontal x axis shifts Trends Lots of information – copies of graphs available

Age at Diagnosis (Years) * In males ** in females *** excluding non-malignant ^ Kaposi sarcoma Average Annual % Change (AAPC) in Incidence of Cancers in AYAs by 15 -Year Age-at-Diagnosis Intervals SEER18 (28% of U.S.) AAPC:

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander BREAST CANCER INCIDENCE per 100,

BREAST CANCER MORTALITY per 100, Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander

BREAST CANCER TRENDS Overall Incidence NS Mortality -3.3

BREAST: Summary Incidence rates – Increase with age – Similar blacks and whites – No trend Mortality rates – Increase with age – Higher in blacks – Decreasing

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander MELANOMA INCIDENCE per 100,

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander MELANOMA MORTALITY per 100,

MELANOMA TRENDS Overall Incidence Males -1.5 Females NS Mortality too low to assess

Melanoma: Summary Incidence rates – Increase with age – Higher in women and in whites – Declining Mortality rates – Increase with age – Higher in whites – No trend assessment

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander COLORECTAL CANCER INCIDENCE per 100,

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander COLORECTAL CANCER MORTALTY per 100,

COLORECTAL CANCER TRENDS Overall Incidence Males +1.2 Females +2.3 Mortality NS

Colorectal: Summary Incidence rates – Increase with age – Modestly higher in males – Increasing Mortality rates – Increase with age – Much higher in blacks – Trend?

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander LEUKEMIA INCIDENCE per 100,

Age Adjusted Incidence Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Death Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Incidence Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Death Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Incidence Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Death Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Incidence Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Age Adjusted Death Rates , Leukemia Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander LEUKEMIA MORTALITY per 100,

LEUKEMIA TRENDS Overall Incidence Males NS Females +2.2 Mortality Males -1.4 Females -2.1

LEUKEMIA: Summary Incidence rates – Modest increase with age – Female less than male – Possible increase in females, particularly older Mortality rates – Modest increase with age – Female less than male – Decreasing, particularly younger females

Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander Ages All Races White Non-Hispanic White Hispanic Black Asian/Pacific Islander SARCOMA INCIDENCE per 100,

SARCOMA TRENDS Incidence NS

SARCOMA Incidence – Occurs across age groups, although still increases with age – More common in black males (& females) – No trend

OVERALL INCIDENCE: SUMMARY Thyroid and kidney carcinoma are dramatically increasing in AYAs and older adults (and for thyroid cancer, also in children). Colorectal and testis carcinoma is increasing in young AYAs but not as rapidly as thyroid and kidney cancer. ALL was increasing in and only in AYAs, but the trend slowed in 2008 (data not shown). Breast cancer may be increasing in young AYAs during the past decade. Melanoma declined in older AYAs as did lung cancer and carcinoma of the cervix in young AYAs.

28 Bleyer 1 in 59 *including “non-invasive”, “benign”, “borderline” 1 in Risk of cancer * from age 15 to 39 SEER18

29 Bleyer 1 in Risk of cancer * from age 15 to 39 SEER18 Females 1 in 44 *including “non-invasive”, “benign”, “borderline”

30 Bleyer 1 in 41 Non-Hispanic White Females 1 in 38 *including “non-invasive”, “benign”, “borderline” Risk of cancer * from age 15 to 39 SEER

31 Bleyer Death Rates

32 Bleyer One of 10 deaths in year-olds is due to cancer (neoplasms) in 10 Same rate since 1988

33 Bleyer One of 14 deaths in year-old males is due to cancer (neoplasms) in 14 Same rate since 1987

34 Bleyer One of 6 deaths in year-old females is due to cancer (neoplasms) in 6 Same rate since 1993

35 Bleyer One of 4 deaths due to disease in year-olds is from a neoplasm in 4 Same rate since 1969

36 Bleyer 1 in 5 One of 5 deaths due to disease in year-old males is from a neoplasm 2010

37 Bleyer 1 in 4 One of 4 deaths due to disease in year-old females is from a neoplasm 2010

Incidence including Cancers with “Non-Malignant” Behavior

Age at Diagnosis (Years) Proportion of All Cancer that is not Reported as Malignant, by Individual Year at Diagnosis, SEER18, AYA 0% 2% 4% 6% 8% 10% 12% 14% 16% 18% AYAs: 12%-16% “Non-Malignant” “Non-Malignant”

Females Males Age at Diagnosis (Years) 0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20% 22% Proportion of All Cancer that is not Reported as Malignant, by Individual Year at Diagnosis and Sex, SEER18, AYA Females: 14%-22% “Non- Malignant” AYA Males: 8%-12% “Non- Malignant” AYA

Years after Diagnosis Non-Malignant Behavior (N=21,566) All Cancer (N=221,793) Malignant Behavior (N=200,227) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Comparison of Survival of All Cancer and of Malignant Cancer, , SEER18 95% C.I. The 95% confidence interval at 10-years for all cancer is 77.7%-78.2%. 95% C.I.

AYA Cancer Survival Trends

AAPC All Other CancerBest Prognosis Annual Average % Change (AAPC) in 5-Year Relative Survival by Age Age at Diagnosis (Years) Hodgkin Lymphoma Melanoma Thyroid Cancer Testicular Carcinoma Except Kaposi Sarcoma and Non-Hodgkin Lymphoma

Beyond Seer: Leveraging and Expanding AYA Data Resources Improving data collection: defining key relevant variables and standardizing collection Data harmonization/pooling in current and future studies Expand capture of population-based AYA cancer epidemiology beyond SEER. Access data captured by Electronic Health Records, Health Information Exchanges, Accountable Care Organizations and Health Insurance Firms.

Beyond Seer: Leveraging and Expanding AYA Data Resources Pursue linkage of data from SEER with Medicaid, state cancer registry data and large insurers Leverage existing and future studies involving AYA that are not cancer focused Conduct an AYA-Focused NCI Patterns of Care Study

Questions for Discussion Can the work of other groups provide a context in which to understand these data? What do these data suggest about future prevention, clinical, and research priorities? What are the next steps in terms of data to address future priorities?

Overall Summary Incidence and mortality rates increase with age – Complex patterns by sex and race/ethnicity Rate trends – Decreasing: breast cancer mortality, melanoma incidence, & leukemia mortality – Increasing: colorectal incidence & leukemia incidence Need additional data sources – Leverage existing study and health plan data – Repeat POC study